Clinical Investigation of Valsartan Sustained-Release Matrix Tablets: Formulation Design and Performance Evaluation
Ramya Teja Medarametla, K. Venkata Gopaiah, J. N. Suresh Kumar, A. Kumar Sai, G. Mohana Chari, A. Kranti Kiran, B. Koteswarao Naik & K. Sandya Rani · Journal of Pharmaceutical Research International · 2024
The primary objective of this main study is to develop and assess the sustained-release matrix tablets containing Valsartan, an angiotensin II receptor type 1 antagonist. The powder mixtures underwent a thorough examination of pre-compression parameters and observed angle of repo...
Open access
Research Article
10.9734/jpri/2024/v36i27500